Keyphrases
Hepatitis C Virus Genotypes
100%
Kupffer Cells
100%
IFN-stimulated Genes
100%
Differential Response
100%
Interferon Therapy
100%
Innate Immune Tolerance
100%
Interferon-α (IFN-α)
66%
Hepatitis C Virus RNA
50%
Non-responders
50%
Interferon alpha-2b
50%
Hepatitis C Virus
33%
Gene Expression
33%
Virologic
33%
Hepatoma Cells
33%
Huh7
33%
Human Macrophages
16%
Liver
16%
Hepatocytes
16%
Blood Samples
16%
MRNA Level
16%
Ribavirin
16%
AIMS™
16%
Basal Expression
16%
Hepatitis C Virus Infection
16%
Nave
16%
Distribution Pattern
16%
Virus-host Interactions
16%
Peripheral Blood Mononuclear Cells
16%
IFN Production
16%
Gene Function
16%
Chronic Hepatitis C Virus Infection
16%
Biopsy Specimen
16%
Acute Response
16%
Treatment Outcome
16%
Hepatic Expression
16%
Expression Distribution
16%
THP1
16%
Liver Biopsy
16%
Chronic Hepatitis C
16%
Tissue Distribution
16%
Gene Expression Analysis
16%
Lack of Response
16%
Hepatic Tissue
16%
Systems Biology Approach
16%
IFN Therapy
16%
Interferon alpha Therapy
16%
Pegylated Interferon alfa-2a
16%
Acute Hepatitis C
16%
Medicine and Dentistry
Infection
100%
Interferon
100%
Hepatitis C Virus
100%
Interferon Alfa
100%
Kupffer Cell
100%
Immunological Tolerance
100%
Hepatitis C Virus Genotype 1
100%
Alpha2a Interferon
80%
Virus RNA
60%
Chronic Hepatitis C
60%
Gene Expression
40%
Hepatoma Cell
40%
Macrophage
20%
Hepatocyte
20%
Hepatitis C
20%
Ribavirin
20%
Gene Expression Profiling
20%
Peripheral Blood Mononuclear Cell
20%
Virus Cell Interaction
20%
Gene Function
20%
Liver Biopsy
20%
Biopsy Sample
20%
Peginterferon Alpha
20%
Immunology and Microbiology
interferon
100%
Hepatitis C Virus
100%
Interferon Alfa
100%
Immune Tolerance
100%
Kupffer Cell
100%
Hepatitis C Virus Genotype 1
100%
Alpha2a Interferon
80%
RNA Virus
60%
Hepatitis C
60%
Gene Expression
40%
Hepatoma Cell
40%
Macrophage
20%
Virus Cell Interaction
20%
Gene Function
20%
Tissue Distribution
20%
Peginterferon Alpha
20%
Peripheral Blood Mononuclear Cell
20%
Gene Expression Assay
20%
Ribavirin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Hepatitis C Virus
100%
Interferon
100%
Alpha Interferon
100%
Hepatitis C Virus Genotype 1
100%
Alpha2a Interferon
80%
Virus RNA
60%
Chronic Hepatitis C
60%
Liver Cell Carcinoma
40%
Hepatitis C
20%
Ribavirin
20%
Peginterferon Alpha
20%